CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancement in oncology information systems
4.1.2. Growing cases of cancer globally
4.1.3. Advantages of OIS over conventional record maintenance practices
4.1.4. Ageing population
4.2. Market Restraints & Challenges
4.2.1. The dearth of healthcare IT professionals
4.2.2. High costs associated with OIS systems
4.3. Market Opportunities
4.3.1. The untapped potential of emerging markets
4.3.2. Use of artificial intelligence (AI) in oncology information systems
Chapter 5 GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET - BY PRODUCT & SERVICES
5.1. Introduction
5.2. Software
5.2.1. Patient information systems
5.2.2. Treatment planning systems
5.3. Professional Services
5.3.1. Consulting/Optimization Services
5.3.2. Implementation services
5.3.3. Post-sale and maintenance services
Chapter 6 GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET – BY APPLICATION
6.1. Introduction
6.2. Medical oncology
6.3. Radiation oncology
6.4. Surgical oncology
Chapter 7 GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET – BY END USER
7.1. Introduction
7.2. Hospitals & physician’s offices
7.3. Government institutions
7.4 Research centers
CHAPTER 8 GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET - COMPANY PROFILES
9.1 Accuray Incorporated.,
9.2. Koninklijke Philips N.V.
9.3. Cerner corporation
9.4. McKesson Corporation.
9.5. Flatiron Health Inc.
9.6. Ray search Laboratories,
9.7. Epic Systems Corporation
9.8. Verian Medical Systems Inc.,
9.9. Elekta AB
9.10. Philips Healthcare.
9.11. CureMD Corporation.
9.12. Bogardus Medical Systems, Inc.
9.13. Jackson health system
9.14. Orthofix international N.V.
CHAPTER 10 GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
